MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway
Oncogene2011Vol. 31(26), pp. 3136–3147
Citations Over Time
Erica Lorenzon, Roberta Colladel, Eva Andreuzzi, Stefano Marastoni, F. Todaro, Mónica Schiappacassi, Giovanni Ligresti, Alfonso Colombatti, Maurizio Mongiat
Related Papers
- → Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.(1993)759 cited
- → Endorepellin laminin‐like globular 1/2 domains bind Ig3–5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro‐angiogenic signaling by VEGFA in endothelial cells(2013)49 cited
- → Vascular Protection by Angiotensin Receptor Antagonism Involves Differential VEGF Expression in Both Hemispheres after Experimental Stroke(2011)48 cited
- → Decay-accelerating Factor Induction on Vascular Endothelium by Vascular Endothelial Growth Factor (VEGF) Is Mediated via a VEGF Receptor-2 (VEGF-R2)- and Protein Kinase C-α/ϵ (PKCα/ϵ)-dependent Cytoprotective Signaling Pathway and Is Inhibited by Cyclosporin A(2004)49 cited
- → High levels of HtrA4 detected in preeclamptic circulation may disrupt endothelial cell function by cleaving the main VEGFA receptor KDR(2019)16 cited